1.02
1.02 (0%)
As of Apr 17, 2025
Iridex Corp [IRIX]
Source:
Company Overview
Iridex Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases.
| Country | United States |
| Headquarters | mountain view, california |
| Phone Number | 6509404700 |
| Industry | manufacturing |
| CEO | David I. Bruce |
| Website | www.iridex.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $48.7 |
| Operating Profit | $-8.3 |
| Net Income | $-8.9 |
| Net Cash | $-4.6 |
Profit Ratios
| Gross Margin | $19.5 |
| Operating Margin | -17.1 |
| Profit as % of Revenues | -218.9% |
| Profit as % of Assets | -28% |
| Profit as % of Stockholder Equity | -424.9% |
Management Effectiveness
| Return on Equity | -424.9% |
| Return on Assets | -30.6% |
| Turnover Ratio | 153.1% |
| EBITA | $-8.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $29.1 |
| Total Liabilities | $27 |
| Operating Cash Flow | $-7.3 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $2.6 |
